Interim report
Page 1
Note : This document has been translated from the Japanese original for reference purposes only . In the event of any discrepancy between this translated document and the Japanese original , the original shall prevail . Company name : Stock exchange listings : Stock code : URL : Representative : Contact : TEL : Consolidated Financial Results for the Three Months Ended June 30 , 2026 ( Under Japanese GAAP ) Scheduled date for dividend payment : Supplementary materials for financial summaries : Financial results briefing : Accounting Standards F Hards Foundation FASF MEMBERSHIP August 7 , 2026 Nomura Micro Science Co. , Ltd. Tokyo Stock Exchange 6254 https://www.nomura-nms.co.jp/english Makoto Uchida , President , Executive Officer Shiro Nishimura , Director , Executive Officer , General Manager of Management Head Office + 81-46-228-5195 Yes None ( Yen amounts are rounded down to millions , unless otherwise noted . ) 1. Consolidated Financial Results for the Three Months Ended June 30 , 2026 ( from April 1 , 2026 to June 30 , 2026 ) ( 1 ) Consolidated operating results ( Percentages indicate YoY changes ) Profit attributable to owners of parent Net sales Operating profit Ordinary profit Three months ended Million yen % Million yen % June 30 , 2026 June 30 , 2025 9,202 ( 25.8 ) 12,403 628 ( 54.4 ) Million yen 342 % Million yen % ( 56.2 ) 239 ( 48.4 ) 62.6 1,378 280.8 782 58.3 464 12.9 Note : Comprehensive income For the three months ended June 30 , 2026 : ¥ 788 million [ 498.5 % ] For the three months ended June 30 , 2025 : ¥ 131 million [ ( 90.9 % ) ] Basic earnings per share Diluted earnings per share Three months ended June 30 , 2026 June 30 , 2025 Yen 6.25 12.27 Yen 6.12 12.11 ( 2 ) Consolidated financial positions As of June 30 , 2026 March 31 , 2026 Reference : Equity As of June 30 , 2026 : Total assets Net assets Million yen 111,078 110,290 Million yen 38,542 39,852 ¥ 37,705 million As of March 31 , 2026 : ¥ 39,309 million Equity - to - assets ratio Net assets per share % 33.9 Yen 982.15 35.6 1,026.65
Page 2
2. Cash dividends Annual dividends per share First quarter-end Second quarter-end Third quarter-end Fiscal year-end Total Yen Yen Yen Yen Yen Fiscal year ended March 31, 2026 - 20.00 - 61.00 81.00 Fiscal year ending March 31, 2027 - Fiscal year ending March 31, 2027 (Forecast) 30.00 - 55.00 85.00 Note: Revisions to the forecast of cash dividends most recently announced: None 3. Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2027 (from April 1, 2026 to March 31, 2027) (Percentages indicate YoY changes) Net sales Operating profit Ordinary profit Profit attributable to owners of parent Basic earnings per share Million yen % Million yen % Million yen % Million yen % Yen Six months ending September 30, 2026 34,500 36.9 3,600 25.8 2,650 28.6 1,961 38.7 51.11 Fiscal year ending March 31, 2027 97,000 72.5 16,000 140.0 15,000 166.5 11,100 190.7 289.21 Note: Revisions to the earnings forecasts most recently announced: None Basic earnings per share for the six months ending September 30, 2026 and the fiscal year ending March 31, 2027 are calculated based on the average number of shares outstanding during the period, which is calculated based on the number of treasury shares at the end of the three months ended June 30, 2026. * Notes (1) Significant changes in the scope of consolidation during the period: None (2) Application of special accounting methods for preparing quarterly consolidated financial statements: Yes Note: For details, please refer to page 8 of the Attached Materials, “2. Quarterly Consolidated Financial Statements and Significant Notes Thereto (3) Notes to Quarterly Consolidated Financial Statements (Notes on Special Accounting Methods for Preparing Quarterly Consolidated Financial Statements).” (3) Changes in accounting policies, changes in accounting estimates, and restatement (i) Changes in accounting policies due to revisions to accounting standards and other regulations: None (ii) Changes in accounting policies due to other reasons: None (iii) Changes in accounting estimates: None (iv) Restatement: None (4) Number of issued shares (common shares) (i) Total number of issued shares at the end of the period (including treasury shares) As of June 30, 2026 40,608,000 shares As of March 31, 2026 40,608,000 shares (ii) Number of treasury shares at the end of the period As of June 30, 2026 2,217,216 shares As of March 31, 2026 2,319,216 shares
Page 3
(iii) Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year) Three months ended June 30, 2026 38,348,117 shares Three months ended June 30, 2025 37,863,728 shares * Review of the Japanese-language originals of the attached quarterly consolidated financial statements by certified public accountants or an audit corporation: None * Proper use of earnings forecasts, and other special matters Forward-looking statements, including the consolidated forecasts stated in these materials, are based on information currently available to the Company and certain assumptions deemed reasonable. Consequently, any statements herein do not constitute assurances regarding actual results by the Company. Results may differ materially from the consolidated forecasts due to various factors. Please refer to the section "(3) Explanation of Consolidated Earnings Forecast and Other Forward-Looking Statements" in "1. Overview of Operating Results" on page 3 of the attached materials for the assumptions underlying the earnings forecasts and cautions concerning their use.
Page 4
1 Attached Material Index Index 1. Overview of Operating Results ............................................................................................................................................................2 (1) Overview of Operating Results for the Three Months Ended June 30, 2026 .............................................................................2 (2) Overview of Financial Position for the Three Months Ended June 30, 2026 .............................................................................3 (3) Explanation of Consolidated Earnings Forecast and Other Forward-Looking Statements.........................................................3 2. Quarterly Consolidated Financial Statements and Significant Notes Thereto .....................................................................................4 (1) Quarterly Consolidated Balance Sheets .....................................................................................................................................4 (2) Quarterly Consolidated Statements of Income and Consolidated Statements of Comprehensive Income .................................6 (Quarterly Consolidated Statements of Income) (cumulative) ...................................................................................................6 (Quarterly Consolidated Statements of Comprehensive Income) (cumulative) .........................................................................7 (3) Notes to Quarterly Consolidated Financial Statements ..............................................................................................................8 (Notes on Special Accounting Methods for Preparing Quarterly Consolidated Financial Statements) ......................................8 (Notes on Segment Information, etc.) .........................................................................................................................................8 (Notes on Significant Changes in the Amount of Shareholders’ Equity) ....................................................................................9 (Notes on Going Concern Assumption) ......................................................................................................................................9 (Notes on Quarterly Consolidated Statements of Cash Flows) ...................................................................................................9 (Notes on Significant Subsequent Events) ................................................................................................................................ 10
Page 5
2 1. Overview of Operating Results (1) Overview of Operating Results for the Three Months Ended June 30, 2026 During the three months ended June 30, 2026, the global economy generally maintained a moderate growth trend, supported by capital investment centered on AI-related fields. On the other hand, in addition to the impact on energy prices and disruptions in logistics caused by heightened tensions in the Middle East, the outlook remained uncertain due to trends in U.S. trade and tariff policies, the stagnation of the Chinese economy, and other factors. In the semiconductor industry, which affects the performance of the Group, continued investment in production capacity and technology upgrades supporting AI-related advanced logic, DRAM, and advanced packaging remained firm. SEMI (Semiconductor Equipment and Materials International) announced that global semiconductor manufacturing equipment sales in the first quarter of 2026 reached US$36.5 billion, up 14% year on year. Under these circumstances, the Group has aimed to expand corporate value and has focused on achieving the Medium-Term Management Plan "Together Toward Transformation 26 (TTT-26)" through (i) improving profitability, (ii) enhancing capital efficiency, (iii) financial optimization and shareholder returns, and (iv) creating social value. As a result, orders received amounted to 38,891 million yen (up 783.4% YoY), Net sales amounted to 9,202 million yen (down 25.8% YoY), Operating profit amounted to 628 million yen (down 54.4% YoY), Ordinary profit amounted to 342 million yen (down 56.2% YoY), and Profit attributable to owners of parent amounted to 239 million yen (down 48.4% YoY). (Orders received) Capital investment by semiconductor-related companies, which are the major customers of the Group, remained firm, and proactive sales activities in Japan and overseas were successful, resulting in orders for large-scale water treatment equipment projects mainly in Japan and East Asia, and orders received increased significantly. (Net sales) Regarding water treatment equipment, due to the completion of large-scale water treatment equipment projects in the United States and Japan, Net sales amounted to 4,365 million yen (down 50.1% YoY). In addition, regarding maintenance and consumables, orders remained firm mainly from semiconductor-related companies, and Net sales amounted to 4,630 million yen (up 31.9% YoY). Regarding other businesses, due to an increase in sales of piping materials for large semiconductor manufacturing equipment, Net sales amounted to 206 million yen (up 46.1% YoY). (Profit) Regarding profits, although the gross profit margin improved due to an increase in the sales composition ratio of maintenance and consumables, gross profit decreased due to factors causing lower revenue, such as the completion of large-scale water treatment equipment projects in the United States and Japan. In addition, due to an increase in Selling, general and administrative expenses, including personnel expenses, profits at each level below Operating profit decreased compared with the same period of the previous year. Operating results by segment are as follows. (i) Japan In addition to the completion of projects for large-scale water treatment equipment, as sales contributions from newly received large-scale orders are expected from the second half onward, Net sales amounted to 3,894 million yen (47.8% decrease YoY). Regarding Operating profit, due to the factor of decreased revenue as well as an increase in Selling, general and administrative expenses, Operating profit amounted to 395 million yen (48.1% decrease YoY). (ii) South Korea Due to progress in construction work for large-scale water treatment equipment orders received by the previous fiscal year, Net sales amounted to 1,374 million yen (up 124.7% YoY), but due to an increase in the cost of some water treatment equipment, Operating profit amounted to 19 million yen (down 67.6% YoY). (iii) China While construction work for large-scale water treatment equipment projects had run its course, orders for maintenance and consumables remained firm, resulting in Net sales of 1,031 million yen (up 4.2% YoY). On the profit side, due to rising costs and an increase in Selling, general and administrative expenses, Operating loss amounted to 24 million yen (Operating profit of 9 million yen in the same period of the previous year). (iv) Taiwan In addition to the smooth progress of construction work on the large-scale water treatment equipment ordered last year, orders for maintenance services and consumables also remained firm, resulting in Net sales of 1,730 million yen (up 168.4% YoY) and Operating profit of 188 million yen (up 0.5% YoY). (v) United States Due to the completion of orders for large-scale water treatment equipment and other factors, Net sales amounted to 1,123 million yen (down 58.1% YoY), and Operating profit was 40 million yen (down 88.9% YoY), resulting in a significant decrease in both sales and profit. (vi) Other Nomura Micro Science Singapore Pte. Ltd., which commenced operations in the previous consolidated fiscal year, saw its business activities progress steadily and secured maintenance projects, resulting in Net sales of 48 million yen
Page 6
3 (up 617.5% YoY) and Operating profit of 8 million yen (compared with an operating loss of 3 million yen in the same period of the previous year). (2) Overview of Financial Position for the Three Months Ended June 30, 2026 Total assets at the end of the current first-quarter consolidated accounting period increased by 787 million yen compared with the end of the previous consolidated fiscal year, to 111,078 million yen. This was mainly due to a decrease in Cash and deposits of 1,951 million yen, while Notes and accounts receivable - trade, and contract assets increased by 2,195 million yen and Other under current assets increased by 769 million yen. Total liabilities increased by 2,097 million yen compared with the end of the previous consolidated fiscal year, to 72,535 million yen. This was mainly due to a decrease of 2,052 million yen in Notes and accounts payable - trade, while Short-term borrowings increased by 3,478 million yen. In addition, net assets decreased by 1,310 million yen compared with the end of the previous consolidated fiscal year, to 38,542 million yen. This was mainly due to increases of 386 million yen in Foreign currency translation adjustment and 161 million yen in Valuation difference on available-for-sale securities, while Retained earnings decreased by 2,095 million yen. (3) Explanation of Consolidated Earnings Forecast and Other Forward-Looking Statements There are no changes to the consolidated forecasts for the fiscal year ending March 31, 2027 from the consolidated forecasts for the second quarter (cumulative) and the full year announced on May 14, 2026.
Page 7
4 2. Quarterly Consolidated Financial Statements and Significant Notes Thereto (1) Quarterly Consolidated Balance Sheets (Thousands of yen) As of March 31, 2026 As of June 30, 2026 Assets Current assets Cash and deposits 10,425,046 8,473,753 Notes and accounts receivable - trade, and contract assets 81,779,595 83,975,353 Electronically recorded monetary claims - operating 1,014,602 765,183 Merchandise and finished goods 392,150 484,699 Work in process 3,593,530 3,588,315 Raw materials and supplies 1,196,126 1,168,026 Other 1,970,333 2,740,127 Allowance for doubtful accounts (383,982) (367,584) Total current assets 99,987,402 100,827,874 Non-current assets Property, plant, and equipment 6,263,117 6,128,091 Intangible assets 79,817 75,155 Investments and other assets 3,959,826 4,046,879 Total non-current assets 10,302,761 10,250,126 Total assets 110,290,164 111,078,001 Liabilities Current liabilities Notes and accounts payable - trade 7,761,144 5,708,776 Short-term borrowings 51,065,800 54,543,830 Accounts payable - other 1,378,414 1,461,743 Income taxes payable 3,450,785 2,732,410 Contract liabilities 1,749,764 2,144,244 Provision for product warranties 354,912 322,788 Provision for bonuses 430,468 774,042 Provision for bonuses for directors 34,744 54,574 Asset retirement obligations 59,323 66,628 Other 1,928,414 2,532,666 Total current liabilities 68,213,771 70,341,704 Non-current liabilities Lease liabilities 1,616,245 1,579,613 Retirement benefit liability 12,316 12,845 Provision for retirement benefits for directors (and other officers) 277,513 288,922 Other 317,387 312,115 Total non-current liabilities 2,223,462 2,193,496 Total liabilities 70,437,233 72,535,200
Page 8
5 (Thousands of yen) As of March 31, 2026 As of June 30, 2026 Net assets Shareholders' equity Share capital 2,236,800 2,236,800 Capital surplus 4,237,497 4,168,698 Retained earnings 30,521,528 28,425,739 Treasury shares (278,917) (266,641) Total shareholders' equity 36,716,908 34,564,596 Accumulated other comprehensive income Valuation difference on available-for-sale securities 523,282 684,986 Deferred gains or losses on hedges (2,151) (1,756) Foreign currency translation adjustment 2,071,140 2,457,657 Total accumulated other comprehensive income 2,592,271 3,140,887 Share acquisition rights 543,750 837,316 Total net assets 39,852,930 38,542,800 Total liabilities and net assets 110,290,164 111,078,001
Page 9
6 (2) Quarterly Consolidated Statements of Income and Consolidated Statements of Comprehensive Income (Quarterly Consolidated Statements of Income) (cumulative) (Thousands of yen) Net sales Three months ended June 30, 2025 Three months ended June 30, 2026 Net sales 12,403,144 9,202,469 Cost of sales 9,621,201 7,055,761 Gross profit 2,781,942 2,146,708 Selling, general and administrative expenses 1,403,394 1,518,695 Operating profit 1,378,548 628,013 Non-operating income Interest income 37,777 13,911 Dividend income 5,245 8,177 Rental income from buildings 8,053 9,048 Foreign exchange gains - 211,908 Other 11,287 32,724 Total non-operating income 62,362 275,768 Non-operating expenses Interest expense 552,563 560,372 Other 105,647 730 Total non-operating expenses 658,210 561,103 Ordinary profit 782,700 342,678 Extraordinary income Gain on sale of non-current assets - 6,115 Gain on sale of investment securities 8,567 - Total extraordinary income 8,567 6,115 Extraordinary losses Loss on retirement of fixed assets 0 0 Total extraordinary losses 0 0 Profit before income taxes 791,268 348,794 Income taxes 326,866 108,967 Profit 464,401 239,826 Profit attributable to owners of parent 464,401 239,826
Page 10
7 (Quarterly Consolidated Statements of Comprehensive Income) (cumulative) (Thousands of yen) Three months ended June 30, 2025 Three months ended June 30, 2026 Profit 464,401 239,826 Other comprehensive income (loss), net of tax Valuation difference on available-for-sale securities 4,319 161,704 Deferred gains or losses on hedges - 394 Foreign currency translation adjustment (336,983) 386,517 Other comprehensive income, net of tax (332,663) 548,615 Comprehensive income 131,737 788,442 Profit attributable to Quarterly comprehensive income attributable to owners of parent 131,737 788,442
Page 11
8 (3) Notes to Quarterly Consolidated Financial Statements (Notes on Special Accounting Methods for Preparing Quarterly Consolidated Financial Statements) (Calculation of Tax Expenses) With regard to income tax expenses, the effective tax rate after applying tax effect accounting to the pre-tax profit for the consolidated fiscal year including the current first-quarter consolidated accounting period is reasonably estimated, and the estimated effective tax rate is applied to the pre-tax profit to calculate the tax expenses. Note that Income taxes - deferred is presented as part of Income taxes. (Notes on Segment Information, etc.) I. First three months of the fiscal year ending March 31, 2026 (From April 1, 2025 to June 30, 2025) Information on Net sales and profit or loss by reportable segment (Thousands of yen) Reportable segment Japan Korea China Taiwan United States Other Total Net sales Net sales to external customers 7,467,044 611,640 990,293 644,844 2,682,614 6,706 12,403,144 Intersegment net sales or transfers 446,123 88,242 1,867 - - - 536,234 Total 7,913,167 699,883 992,161 644,844 2,682,614 6,706 12,939,378 Segment profit or Loss (-) 763,455 60,446 9,057 187,687 361,197 (3,296) 1,378,548 Adjustments Amount recorded in quarterly consolidated statements of income (Note) Net sales Net sales to external customers - 12,403,144 Intersegment net sales or transfers (536,234) - Total (536,234) 12,403,144 Segment profit or Loss (-) - 1,378,548 Note: Segment profit or loss is consistent with operating profit in the quarterly consolidated statements of income.
Page 12
9 II. First three months of the fiscal year ending March 31, 2027 (From April 1, 2026 to June 30, 2026) Information on amounts of Net sales and profit or loss by reportable segment (Thousands of yen) Reportable segment Japan Korea China Taiwan United States Other Total Net sales Net sales to external customers 3,894,285 1,374,077 1,031,981 1,730,961 1,123,040 48,123 9,202,469 Intersegment net sales or transfers 1,416,274 36,371 4,936 - - - 1,457,582 Total 5,310,560 1,410,448 1,036,917 1,730,961 1,123,040 48,123 10,660,052 Segment profit or Loss (-) 395,942 19,558 (24,654) 188,664 40,086 8,415 628,013 Adjustments Amount recorded in quarterly consolidated statements of income (Note) Net sales Net sales to external customers - 9,202,469 Intersegment net sales or transfers (1,457,582) - Total (1,457,582) 9,202,469 Segment profit or Loss (-) - 628,013 Note: Segment profit or loss is consistent with operating profit in the quarterly consolidated statements of income. (Notes on Significant Changes in the Amount of Shareholders’ Equity) Not applicable. (Notes on Going Concern Assumption) Not applicable. (Notes on Quarterly Consolidated Statements of Cash Flows) A quarterly consolidated Statements of cash flows for the current first-quarter consolidated cumulative period has not been prepared. In addition, depreciation for the first-quarter consolidated cumulative period (including amortization related to intangible assets) is as follows. (Thousands of yen) Three months ended June 30, 2025 Three months ended June 30, 2026 Depreciation 564,475 365,670
Page 13
10 (Notes on Significant Subsequent Events) (Issuance of share acquisition rights as stock options) At the Board of Directors meeting held on July 15, 2026, the Company resolved to issue share acquisition rights as stock options to its executive officers (excluding those who concurrently serve as directors; the same applies hereinafter) and employees. (1) Reason for issuing share acquisition rights as stock options The purpose is to further strengthen the linkage between the Company's performance and shareholder value, and to enhance the motivation and morale of the Company's executive officers and employees to contribute to medium- to long-term performance improvement and enhancement of corporate value. (2) Outline of issuance of share acquisition rights (i) Persons eligible for allotment of share acquisition rights Executive officers and employees of the Company (ii) Class and number of shares underlying share acquisition rights Up to 254,500 shares of the Company's common stock. In the event that the Company conducts a stock split or share consolidation, the number of shares subject to the share acquisition rights shall be adjusted in accordance with the following formula. However, such adjustment shall be made only with respect to the number of shares subject to the share acquisition rights that have not been exercised at that time, and if any fraction of less than 1 share arises as a result of the adjustment, such fraction shall be rounded down. Adjusted number of shares = Number of shares before adjustment × ratio of stock split or share consolidation (iii) Number of share acquisition rights Up to 2,545 units. The number of shares underlying one share acquisition right (hereinafter referred to as the "Number of Granted Shares") shall be 100 shares. However, if an adjustment is made to the number of shares specified in (ii) above, a similar adjustment shall be made. (iv) Issuance price of share acquisition rights No consideration shall be provided. (v) Value of property to be contributed upon exercise of share acquisition rights The value of property contributed upon exercise of share acquisition rights shall be the amount obtained by multiplying the payment amount per share of stock that may be delivered upon exercise of share acquisition rights (hereinafter referred to as the "exercise price") by the number of granted shares. The exercise price shall be the higher of the amount obtained by multiplying by 1.05 the average of the closing prices of the Company's common shares in regular trading on the Tokyo Stock Exchange on each day (excluding days on which no transaction is effected) of the month preceding the month to which the allotment date belongs, with any fraction of less than 1 yen rounded up, or the closing price on the allotment date (or, if no transaction is effected on that date, the closing price on the most recent preceding day). In addition, if the Company conducts a stock split or share consolidation after the allotment date of the share acquisition rights, the exercise price shall be adjusted in accordance with the following formula, and any fraction of less than 1 yen resulting from the adjustment shall be rounded up. Adjusted exercise price = Exercise price before adjustment × 1 Stock split / Share consolidation ratio Also, if after the allotment date of the share acquisition rights, the Company issues new shares of its common stock or carries out Disposal of treasury shares at a price below market value, the exercise price shall be adjusted in accordance with the following formula, and any fraction of less than 1 yen resulting from the adjustment shall be rounded up.
Page 14
11 Number of issued shares + Number of newly issued shares × Amount paid in per share Adjusted exercise price = Exercise price before adjustment × Market value Number of issued shares + number of newly issued shares (vi) Period during which share acquisition rights may be exercised From August 21, 2028 to August 18, 2033 (vii) Conditions for exercise of share acquisition rights (a) A person who has been allotted share acquisition rights (hereinafter referred to as a "Share acquisition rights holder") may exercise the share acquisition rights only if, at the time of exercising the share acquisition rights, such person holds any of the positions of director, corporate auditor, executive officer, employee, or any equivalent position at the Company or its subsidiaries. Notwithstanding the foregoing, if a share acquisition rights holder retires from the position of director or corporate auditor of the Company or its subsidiaries upon expiration of the term of office, retires from employment with the Company or its subsidiaries upon reaching the mandatory retirement age, or loses any of the positions of director, corporate auditor, executive officer, employee, or any equivalent position at the Company or its subsidiaries for justifiable reasons, such person may exercise the share acquisition rights. (b) If a holder of share acquisition rights dies before the expiration of the period during which the share acquisition rights may be exercised, such holder shall forfeit those rights. (c) No transfer, pledge, or any other disposition whatsoever of all or part of the share acquisition rights shall be permitted. (d) Other conditions for the exercise of rights shall be as provided in the share acquisition rights allotment agreement entered into between the Company and the person receiving the allotment of share acquisition rights. (viii) Restrictions on transfer of share acquisition rights The transfer of share acquisition rights shall require the approval of the Board of Directors. (ix) Matters concerning share capital and legal capital surplus to be increased when issuing shares upon exercise of share acquisition rights (a) In the event that shares are issued upon exercise of share acquisition rights, the amount of increase in share capital shall be one-half of the maximum amount by which share capital, etc. may be increased, calculated in accordance with Article 17, Paragraph 1 of the Regulation on Corporate Accounting, and if any fraction of less than 1 yen arises as a result of the calculation, such fraction shall be rounded up. (b) In the event that shares are issued upon exercise of share acquisition rights, the amount of increase in legal capital surplus shall be the amount obtained by deducting the amount of increase in share capital specified in (a) above from the upper limit of increase in share capital, etc. specified in (a) above.